Large Study Links GLP-1s to Lower Risk of Multiple Cancers

(MedPage Today) -- Patients taking GLP-1 receptor agonists for obesity had a 41% lower risk of obesity-related cancers as compared with patients treated with diet or exercise, a large propensity-matched cohort study showed.
After 2 years of follow...